IL-6 shows a synergistic effect with other mediators of metabolic disease, collectively contributing to the progression of other obesity-associated comorbidities such as CAD and T2DM [64, 69]
(January 2005)
Peroxisome proliferator activator receptor (PPAR)- ligand, but not PPAR-, ameliorates cyclophosphamide-induced oxidative stress and inflammation in rat liver
Vaz and Wanders, 2002)
Sikiric, P., Seiwerth, S., Grabarevi, ., Petek, M., Ruman, R., Turkovi, B., Rotkvi, I., Jagi, V., Duvnjak, M., Mie, S., Djai, S., eparovi, J., Veljaa, M., Sallmani, A., Banic, M., & Brki, T
Take that first step toward feeling your absolute best